Ki-ras mutations and prognosis in colorectal cancer

By Kressner U.   Bjorheim J.   Westring S.   Wahlberg S.S.   Pahlman L.   Glimelius B.   Lindmark G.   Lindblom A.   Borresen-Dale A.-L.  

European Journal of Cancer, Vol. 34, Iss. 4, 1998-03 ,pp. : 518-521

Elsevier

Access to resources Recommend Favorite

K-ras mutations in colorectal adenocarcinomas and neighbouring transitional mucosa

By Zhang H.   Nordenskjold   Dufmats M.   Soderkvist P.   Sun X.-F.  

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2053-2057

Elsevier

Access to resources Recommend Favorite

Ras-related C3 botulinum toxin substrate 1 activation is involved in the pathogenesis of diabetic retinopathy

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 1, 2015-01 ,pp. : 89-97

Spandidos Publications

Access to resources Recommend Favorite

Mitotic Count, Nuclear Atypia, and Immunohistochemical Determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 Expression in Granulosa Cell Tumors of the Ovary: Mitotic Count and Ki-67 Are Indicators of Poor Prognosis

By King L.A.   Okagaki T.   Gallup D.G.   Twiggs L.B.   Messing M.J.   Carson L.F.  

Gynecologic Oncology, Vol. 61, Iss. 2, 1996-05 ,pp. : 227-232

Academic Press

Access to resources Recommend Favorite

Comparison of advanced adenocarcinomas of esophagogastric junction and distal stomach in Japanese patients

By Kawano Akiko   Nakajima Takako   Oda Ichiro   Hokamura Nobukazu   Iwasa Satoru   Kato Ken   Hamaguchi Tetsuya   Yamada Yasuhide   Fujii Hirofumi   Shimada Yasuhiro  

Gastric Cancer, Vol. 17, Iss. 1, 2014-01 ,pp. : 54-60

Springer Publishing Company

Access to resources Recommend Favorite